Juan Boriosi, MD, recently received over $110,000 from Isomark, LLC, for his 1-year project, “Changes in 13C/12C delta value in breath as a biomarker of systemic inflammatory response syndrome in mechanically ventilated pediatric and adult …
Boriosi Research Group News
Dr. Juan Boriosi Participating in Hospira, Inc. Clinical Trial
Juan Boriosi, MD, is participating in a clinical trial with Hospira, Inc., entitled, “A Phase III, Randomized, Double-Blind, Dose-Controlled, Multicenter, Study Evaluating the Safety and Efficacy of Dexmedetomidine in Intubated and Mechanically Ventilated Pediatric Intensive …